Trials / Completed
CompletedNCT06104098
A User Study With Vernivia® for Bacterial Vaginosis.
A User Study With Vernivia® for Bacterial Vaginosis (USV01) Evaluation of User-friendliness, Measure Time From the Start of Treatment to Symptom Relief and the Clarity of Instructional Material
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- PepTonic Medical AB · Industry
- Sex
- Female
- Age
- 16 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
This is an open user study to evaluate D005 vagnial mousse with regards to user-friendliness, and measure time from start of treatment to symptom relief and measure the clarity of instructional material. The study will be conducted at seven sites in Sweden, the study population will consist of up to 100 female subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | D005 vaginal mousse | D005 Vaginal Mousse is class IIa medical device for treatment of Bacterial Vaginosis. |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2021-07-20
- Completion
- 2021-07-22
- First posted
- 2023-10-27
- Last updated
- 2023-10-31
Locations
7 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT06104098. Inclusion in this directory is not an endorsement.